Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Naltrexone vs ARVs in HIV+ Progression
NCT01174914Phase 2Completed
- Sponsor
- The Ojai Foundation
- Start
- Mar 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of naltrexone in human immunodeficiency virus infection (HIV), sponsored by The Ojai Foundation. Started Mar 2008; status: completed.
02
Drugs
naltrexone
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01174914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01174914.